In addition to that, the recent decision of CVS to make Wegovy the only GLP-1 medicine covered for obesity on its national template formulary starting July 1, 2025, also adds tremendous opportunity ...

By Amina Niasse (Reuters) -Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up ...